Compare KGC & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KGC | CNC |
|---|---|---|
| Founded | 1993 | 1984 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medical Specialities |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.1B | 33.5B |
| IPO Year | 1994 | 2001 |
| Metric | KGC | CNC |
|---|---|---|
| Price | $28.25 | $69.38 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 16 |
| Target Price | $31.71 | ★ $46.75 |
| AVG Volume (30 Days) | ★ 6.8M | 2.8M |
| Earning Date | 04-29-2026 | 04-28-2026 |
| Dividend Yield | ★ 0.45% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 5.30 |
| Revenue | N/A | ★ $194,777,000,000.00 |
| Revenue This Year | $38.70 | $8.31 |
| Revenue Next Year | N/A | $1.05 |
| P/E Ratio | $24.18 | ★ $12.53 |
| Revenue Growth | N/A | ★ 19.44 |
| 52 Week Low | $21.94 | $31.63 |
| 52 Week High | $39.11 | $69.36 |
| Indicator | KGC | CNC |
|---|---|---|
| Relative Strength Index (RSI) | 43.46 | 56.08 |
| Support Level | $26.72 | $63.36 |
| Resistance Level | $29.14 | $68.48 |
| Average True Range (ATR) | 0.99 | 1.98 |
| MACD | -0.55 | 0.07 |
| Stochastic Oscillator | 0.98 | 78.99 |
Kinross Gold is a Canada-based gold producer, producing roughly 2 million gold equivalent ounces in 2025. The company had about a decade of gold reserves at the end of 2025. It operates mines in the Americas and West Africa after selling its low-cost Russian operations in 2022 in response to the invasion of Ukraine. Kinross has historically used acquisitions to fuel expansion into new regions and production growth. In 2022, Kinross purchased the Great Bear project in Canada. If developed as we think likely, it could produce an average of more than 500,000 ounces of gold per year for at least a decade, with its unit cash costs likely in the first quartile of the industry cost curve. Though Great Bear's production is likely to be replacement ounces for falling volumes at other mines.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.